Test Blueprint
-
Health Promotion and Disease Prevention – 5% of test content
- Epidemiology (e.g., at-risk populations including cultures; socioeconomic status; age; occupations)
- Prevention (e.g., high risk behaviors; preventive health practices)
-
Screening, Early Detection and Diagnosis – 7% of test content
- Risk factors for cancer
- Screening
- Early detection
- Risk Reduction Guidelines
- Diagnostic testing
-
Scientific Basis for Practice including Research – 10% of test content
- Carcinogenesis
- Immunology
- Genetics
- Specific cancers (pathophysiology, diagnostic measures, prognosis)
- Classification (tumors, staging, grading)
- Common metastatic sites
- Research Protocols and Clinical Trials
-
Cancer Treatment Modalities – 15% of test content
- Vascular access devices
- Surgery
- Radiation
- Targeted therapies
- Biotherapy
- Chemotherapy
- Hematopoietic stem cell transplant
- Complementary, alternative and integrative modalities
-
Symptom Management – 22% of test content
(risk factors, prevention, education, management, and palliative care using the nursing process)
- Etiology and patterns of symptoms (acute, chronic, late)
- Toxicity and rating scales
- Alterations in comfort
- Alterations in protective mechanisms
- Alterations in gastrointestinal function
- Alterations in genitourinary function
- Alterations in respiratory function
- Alterations in circulatory function
- Alterations in nutrition
- Alterations in neurological function
- Anatomical and surgical alterations
- Pharmacologic interventions (e.g., antimicrobials; antiemetics; analgesic regimens; psychotropic drugs; growth factors)
- Nonpharmacologic interventions (e.g., heat; massage; imagery)
- Complementary, alternative and integrative modalities
-
Psychosocial Dimensions of Care – 7% of test content
- Cultural, spiritual, and religious diversity
- Financial concerns
- Psychosocial disturbances-alterations
- Anxiety, loss and grief, depression
- Altered body image
- Loss of personal control
- Patient and family support groups
- Learning styles and barriers to learning
- Social relationships
- Coping mechanisms and skills
-
Oncologic Emergencies – 10% of test content
(risk factors, prevention, education and management using the nursing process, including pharmacologic and nonpharmacologic interventions)
- Disseminated intravascular coagulation (DIC)
- Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
- Septic shock
- Tumor lysis syndrome
- Hypersensitivity and/or anaphylaxis
- Hypercalcemia
- Cardiac tamponade
- Spinal cord compression
- Superior vena cava syndrome
- Increased intracranial pressure
-
Sexuality – 5% of test content
(risk factors, prevention, education, and management using the nursing process, including pharmacologic and nonpharmacologic interventions)
- Reproductive issues (contraception and fertility)
- STD and HIV risk
- Sexual dysfunction (physical and psychological effects)
-
Survivorship – 8% of test content
(concept, education and management using the nursing process)
- Psychosocial, physical and cognitive alterations
- Issues (e.g., financial; employment; insurance; discrimination; family and social support)
- Acute effects
- Late effects
- Recurrence and/or secondary malignancies
- Rehabilitation and long term follow up
-
End of Life Care – 6% of test content
(principles, complex symptom management including pharmacologic and nonpharmacologic interventions, family support and education)
- Grief and bereavement process
- Reimbursement issues and community resources
- Hospice (e.g., principles, settings for care)
-
Professional Performance – 5% of test content
- Local, state, and national resources
- Application of statement on the scope and standards of oncology nursing practice
- Sources of data for evidence-based practice
- Education process (teaching and learning principles)
- Legal issues
- Ethical issues
- Patient advocacy
- Quality assurance
- Professional development
- Multidisciplinary collaboration